Inventor · disambiguated record
Jerôme Hubertina Henricus Victor Custers
Also filed as: CUSTERS JEROME H H V · CUSTERS JEROME H HV · CUSTERS JEROME HUBERTINA H V · CUSTERS JEROME HUBERTINA HENRI
22 granted patents·3 pending applications·56 citations·filing 1999–2021
93Inventor score
Files withJANSSEN VACCINES & PREVENTION BV18JANSSEN SCIENCES IRELAND UNLIMITED CO2CRUCELL HOLLAND BV1SYNGENTA LTD1SYNGENTA MOGEN BV1
Top patents by PatentIndex Score
25 records- 0193US11020476B2Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)JANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2018·Granted Jun 1, 2021·13 cites·20 claims
- 0292US9790256B2Therapeutic HPV18 vaccinesJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Oct 17, 2017·14 cites·28 claims
- 0387US10744196B2HPV vaccinesJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Aug 18, 2020·4 cites·25 claims
- 0487US10071151B2Therapeutic HPV16 vaccinesJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Sep 11, 2018·5 cites·21 claims
- 0586US11723970B2Poxvirus vectors encoding HIV antigens, and methods of use thereofJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Aug 15, 2023·1 cites·20 claims
- 0681US10555996B2Therapeutic HPV16 vaccinesJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Feb 11, 2020·2 cites·28 claims
- 0779US9701721B2Therapeutic HPV16 vaccinesCRUCELL HOLLAND BV·Filed 2015·Granted Jul 11, 2017·2 cites·21 claims
- 0878US11229693B2Poxvirus vectors encoding HIV antigens, and methods of use thereofJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Jan 25, 2022·1 cites·20 claims
- 0972US10844096B2Therapeutic HPV18 vaccinesJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Nov 24, 2020·0 cites·26 claims
- 1068US11040096B2Therapeutic HPV16 vaccinesJANSSEN VACCINES & PREVENTION BV·Filed 2020·Granted Jun 22, 2021·0 cites·20 claims
- 1163US11142551B2Adenovirus and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Oct 12, 2021·0 cites·15 claims
- 1262US11872281B2Adenovirus and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Jan 16, 2024·0 cites·25 claims
- 1362US11236361B2Adenovirus and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Feb 1, 2022·0 cites·17 claims
- 1461US2021268104A1Methods and Compositions for Inducing an Immune Response Against Hepatitis B Virus (HBV)JANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Application pending·0 cites
- 1560US11459583B2Adenovirus vectors and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Oct 4, 2022·0 cites·14 claims
- 1659US10287323B2Therapeutic HPV18 vaccinesJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted May 14, 2019·0 cites·22 claims
- 1753US6774281B1Method for the induction of pathogen resistance in plantsSYNGENTA MOGEN BV·Filed 1999·Granted Aug 10, 2004·9 cites·6 claims
- 1851US2022372515A1Adenovirus vectors and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2020·Application pending·0 cites
- 1948US10570417B2Recombinant adenovirus expressing two transgenes with a bidirectional promoterJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Feb 25, 2020·0 cites·11 claims
- 2046US10517938B2Adenovirus based malaria vaccine encoding and displaying a malaria antigenJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Dec 31, 2019·0 cites·16 claims
- 2145US7199235B2Plant promotersSYNGENTA LTD·Filed 2002·Granted Apr 3, 2007·0 cites·8 claims
- 2241US6465636B1Pathogen-inducible promoterZENECA MOGEN B V·Filed 1999·Granted Oct 15, 2002·5 cites·13 claims
- 2336US10517944B2Therapeutic HPV vaccine combinationsJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Dec 31, 2019·0 cites·20 claims
- 2435US2004191912A1New constitutive plant promoterFiled 2002·Application pending·0 cites
- 2531US10238730B2Cold-adapted-viral-attenuation (CAVA) and novel attenuated poliovirus strainsJANSSEN VACCINES & PREVENTION BV·Filed 2015·Granted Mar 26, 2019·0 cites·22 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →